Gerard Silvestri, MD
Enriched profileHillenbrand Distinguished University Professor of Thoracic Oncology (George C. and Margaret M. Hillenbrand Endowed Chair); Professor of Medicine, Division of Pulmonary, Critical Care, Allergy & Sleep Medicine · Medical University of South Carolina (MUSC)
Gerard Silvestri is Hillenbrand Distinguished University Professor of Thoracic Oncology (George C. and Margaret M. Hillenbrand Endowed Chair); Professor of Medicine, Division of Pulmonary, Critical Care, Allergy & Sleep Medicine at Medical University of South Carolina (MUSC). OpenAlex indexes 473 publications with 23,148 citations (h-index 76); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Gerard Silvestri, MD, is Hillenbrand Distinguished University Professor of Thoracic Oncology (George C. and Margaret M. Hillenbrand Endowed Chair) at Medical University of South Carolina (MUSC), Department of Medicine, Division of Pulmonary, Critical Care, Allergy & Sleep Medicine. The public record shows 473 publications with 23,148 citations (h-index 76), centered on Respiratory. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2007–2011).
- Most recent indexed publication: 2026 · American journal of respiratory and critical care medicine
- Top research focus: Respiratory
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
Sponsor: Biodesix, Inc.
- Robotic Bronchoscopy for Peripheral Pulmonary Lesions
Sponsor: Auris Health, Inc.
- A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
Sponsor: Paion UK Ltd.
Industry payments
Updated 27 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202518 payments$15,221openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20251 payment
- Olympus Corporation of the AmericasProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%beta2-Adrenergic Agonist63%Albuterol Sulfate Hfa100%Part D≥14 patientsCorticosteroid37%Trelegy Ellipta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
University of Florida
FY2025$637,797R01CA249506 - Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
University of Florida
FY2024$608,786R01CA249506 - Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
University of Florida
FY2024$65,002R01CA249506
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Nicotine replacement therapy starter packs and gain-framed messages to promote smoking cessation in lung cancer screening: a randomized trial.
American journal of respiratory and critical care medicine
Article2026 - Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.
Cancer discovery
Article2024 - Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Chest Physicians Research Statement.
American journal of respiratory and critical care medicine
Article2024 - Reducing Disparities in Lung Cancer Screening: It's Not So Black and White.
Journal of the National Cancer Institute
Comment2021
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/gerard-silvestri-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
reachmd.com/programs/deep-breaths-updates-chest
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/MUSCHollings/videos/dr-gerard-silvestri-for-shine-a-light-on-lung-cancer/3468619766557970
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/accpchest/videos/what-is-this-chest-congress-all-about-dr-gerard-silvestri-md-ms-fccp/189407472137262
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
thoracic.org/about/ats-podcasts/the-art-of-contract-negotiation.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thoracic.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
St. George's University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →getcare.muschealth.org ↗ - MS (Health Services Research)
Dartmouth
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →getcare.muschealth.org ↗ - Fellowship
Pulmonary Disease and Critical Care Medicine, Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →getcare.muschealth.org ↗ - Internal Medicine Residency
Hospital of St. Raphael's/Yale University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →getcare.muschealth.org ↗ - Board Certified
Pulmonary Disease and Critical Care Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →muschealth.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →education.musc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthmanagement.org ↗
- Editorial Board
journal CHEST
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ilcn.org ↗
Awards & honors
honors on the public record- Master Fellow
American College of Chest Physicians (Master FCCP), 2022, one of only ~40 in the organization's nearly 90-year history
2022provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nlcrt.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.musc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ilcn.org ↗
Secondary affiliations
appointments beyond the home institution- Data and Safety Monitoring Board
national Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (lung arm representative)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Advisory Committee
ACCC NSCLC Operational Pathways
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →accc-cancer.org ↗ - Member
National Lung Cancer Roundtable (NLCRT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nlcrt.org ↗
Media & interviews
press, podcasts and appearances- "Mythbusting Lung Cancer Screening"
5-part ACR Bulletin Podcast series with Dr. Debra Dyer
- Guest
"Pleural Space: Conversations in Lung Cancer" podcast, discussion with Dr. Ella Kazerooni and Dr. Robert Smith on lung cancer screening advances
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Reddit r/science "Ask Me Anything" (AMA) as President of the American College of Chest Physicians
discussing barriers and diagnosis/treatment of lung cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →authorea.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Diane Kamen, MD
Medical University of South Carolina (MUSC)
Gary Gilkeson, MD
Medical University of South Carolina (MUSC)
Patrick Flume, MD
Medical University of South Carolina (MUSC)